L. R. Mingote

Most-cited papers

Engaging communities in tuberculosis research.
Renaud F. Boulanger, S. Seidel, E. Lessem, L. Pyne-Mercier +5 more
2013Lancet. Infectious Diseases (Print)41 citations
Semantic Scholar
How ethical is your clinical trial?
L. Miller, M. Foláyan, D. Allman, B. Nkala +6 more
2010International journal of clinical practice19 citations Open access
Semantic Scholar
The use of bedaquiline in regimens to treat drug-resistant and drug-susceptible tuberculosis: a perspective from tuberculosis-affected communities.
L. R. Mingote, D. Namutamba, Francis Apina, Nomampondo Barnabas +8 more
2015The Lancet18 citations
Semantic Scholar
The evolving role of advocacy in tuberculosis.
A. DeLuca, E. Lessem, D. Wegener, L. R. Mingote +2 more
2014The Lancet Respiratory Medicine15 citations
Semantic Scholar
Activism on rifapentine pricing: removing cost barriers to improve the uptake of tuberculosis research innovations.
A. Deluca, M. Frick, E. Lessem, J. Kanouse +2 more
2014Public Health Action10 citations Open access
Semantic Scholar
Developing a framework for evaluating ethical outcomes of Good Participatory Practices in TB Clinical Drug Trials
K. MacQueen, Natalie T. Eley, M. Frick, L. R. Mingote +4 more
2016Journal of Empirical Research on Human Research Ethics6 citations Open access
Semantic Scholar
Real engagement with communities.
L. R. Mingote, Wim Vandevelde, B. Kumar, E. Lessem
2015The Lancet Respiratory Medicine2 citations Open access
Semantic Scholar
Informed use of bedaquiline for tuberculosis--Authors' reply.
L. R. Mingote, D. Namutamba, B. Seaworth, Cynthia Lee +1 more
2015The Lancet0 citations
Semantic Scholar
Tuberculosis 2013: 6 Engaging communities in tuberculosis research
J. Lavery, Renaud F. Boulanger, S. Seidel, E. Lessem +5 more
20130 citations
Semantic Scholar